基本信息
views: 2
Career Trajectory
Bio
No content for now
Research Interests
Papers共 39 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
N. Heersche, D.A.C. Lanser, B. Muntinghe, M.I. Mohmaed Ali,E.B. Ulas, T.M.A. Trooster, E. de Jonge, E. Oomen-de Hoop,M.S. Paats,I. Bahce,S. Croes,L.E. Hendriks,A.J. Van Der Wekken,A-M.C. Dingemans, A.D.R. Huitema, R. Van Schaik,R.H. Mathijssen,M.G.D. Veerman
Annals of Oncology (2024)
CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGYno. 4 (2024): 612-623
Ard van Veelen,G. D. Marijn Veerman,Marjon V. Verschueren,Judith L. Gulikers,Christi M. J. Steendam,Anita J. W. M. Brouns,Safiye Dursun,Marthe S. Paats,Vivianne C. G. Tjan-Heijnen,Cor van der Leest,Anne-Marie C. Dingemans,Ron H. J. Mathijssen,Ewoudt M. W. van de Garde,Patrick Souverein,Johanna H. M. Driessen,Lizza E. L. Hendriks,Robin M. J. M. van Geel,Sander Croes
INTERNATIONAL JOURNAL OF CANCERno. 2 (2024): 332-342
B. C. Agema, M. Berrich, L. Seuren, S. D. T. Sassen,J. R. Miedema,B. C. P. Koch,M. S. Wijsenbeek,S. L. W. Koolen,R. H. J. Mathijssen,G. D. M. Veerman
Biomedicine & Pharmacotherapy (2024): 117341-117341
D.A.C. Lanser,N. Heersche, E. Oomen-de Hoop, A. Icli,P. de Bruijn,M.S. Paats, E. van Rossum,S.L. Koolen, R. Van Schaik,A-M.C. Dingemans,M.G.D. Veerman,R.H. Mathijssen
Annals of Oncology (2024)
Journal of pharmaceutical and biomedical analysis (2023): 115233-115233
Biomedicine & pharmacotherapy (2023): 114823-114823
Journal of Clinical Oncologyno. 16_suppl (2023): e21138-e21138
Load More
Author Statistics
#Papers: 39
#Citation: 305
H-Index: 9
G-Index: 17
Sociability: 5
Diversity: 2
Activity: 31
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn